COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 4 of 6 for:    Manic Episodes paliperidone

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00309699
Recruitment Status : Completed
First Posted : April 3, 2006
Last Update Posted : June 20, 2014
Information provided by (Responsible Party):
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2007
Actual Study Completion Date : November 2007